Premium
CYP21A2 mutation update: Comprehensive analysis of databases and published genetic variants
Author(s) -
Simonetti Leandro,
Bruque Carlos D.,
Fernández Cecilia S.,
BenavidesMori Belén,
Delea Marisol,
Kolomenski Jorge E.,
Espeche Lucía D.,
Buzzalino Noemí D.,
Nadra Alejandro D.,
Dain Liliana
Publication year - 2018
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.23351
Subject(s) - congenital adrenal hyperplasia , biology , dbsnp , genetics , database , allele , 21 hydroxylase , gene , phenotype , mutation , genome , genotype , single nucleotide polymorphism , computer science
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders of adrenal steroidogenesis. Disorders in steroid 21‐hydroxylation account for over 95% of patients with CAH. Clinically, the 21‐hydroxylase deficiency has been classified in a broad spectrum of clinical forms, ranging from severe or classical, to mild late onset or non‐classical. Known allelic variants in the disease causing CYP21A2 gene are spread among different sources. Until recently, most variants reported have been identified in the clinical setting, which presumably bias described variants to pathogenic ones, as those found in the CYPAlleles database. Nevertheless, a large number of variants are being described in massive genome projects, many of which are found in dbSNP, but lack functional implications and/or their phenotypic effect. In this work, we gathered a total of 1,340 GVs in the CYP21A2 gene, from which 899 variants were unique and 230 have an effect on human health, and compiled all this information in an integrated database. We also connected CYP21A2 sequence information to phenotypic effects for all available mutations, including double mutants in cis. Data compiled in the present work could help physicians in the genetic counseling of families affected with 21‐hydroxylase deficiency.